Last reviewed · How we verify

NCT05495841

OPTiMASK: Comparison of Pre-oxygenation With Standard Face Mask Combined With High Flow Nasal Oxygen With Pre-oxygenation With Standard Face Mask Alone

Completed Last updated 30 November 2023
What this trial tests

trial testing Pre-oxygenation in Surgery in 80 participants. Completed in 30 June 2023.

Timeline
18 August 2022
Primary endpoint
30 June 2023
30 June 2023

Quick facts

Lead sponsorBeth Israel Deaconess Medical Center
StatusCompleted
Study typeOBSERVATIONAL
Enrollment80
Start date18 August 2022
Primary completion30 June 2023
Estimated completion30 June 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Beth Israel Deaconess Medical Center

Who can join

18 and older, any sex, with Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an observational, prospective study of patients undergoing a surgical procedure. Three parallel studies are taking place with collaborators in other countries. This study aims to bring novel insights regarding the benefits of pre-oxygenation combining standard oxygen facemask with high-flow nasal oxygen (HFNO), as opposed to standard oxygen facemask alone by assessing end-tidal oxygen (ETO2) levels after intubation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Preoxygenation with standard facemask combining apnoeic oxygenation using high flow nasal cannula versuss standard facemask alone in patients with and without obesity: the OPTIMASK international study.
    Jaber S, De Jong A, Schaefer MS, Zhang J, et al · · 2023 · cited 9× · PMID 37014462 · DOI 10.1186/s13613-023-01124-x

Verify or expand the search:

Other trials of Pre-oxygenation

Trials testing the same drug.

Other recruiting trials for Surgery

Currently open trials in the same condition.

Other Beth Israel Deaconess Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05495841.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing